G Gatti

Summary

Affiliation: San Martino Hospital
Country: Italy

Publications

  1. ncbi The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring
    G Gatti
    Department of Infectious Diseases, University of Genoa, Italy
    AIDS 13:2083-9. 1999
  2. ncbi Pharmacokinetics of rifabutin in HIV-infected patients with or without wasting syndrome
    G Gatti
    First Department of Infectious Diseases, University of Genoa, Genoa, Italy
    Br J Clin Pharmacol 48:704-11. 1999
  3. ncbi Indinavir pharmacokinetics and parmacodynamics in children with human immunodeficiency virus infection
    G Gatti
    Department of Infectious Diseases, University of Genoa, Genoa, Italy
    Antimicrob Agents Chemother 44:752-5. 2000
  4. ncbi The relationship between ritonavir plasma trough concentration and virological and immunological response in HIV-infected children
    G Gatti
    I Department of Infectious Diseases c o G Gaslini Institute University of Genoa, Genoa, Italy
    HIV Med 3:125-8. 2002
  5. ncbi Tenofovir use in a patient with a severe renal impairment
    A Di Biagio
    Department of Infectious Diseases, San Martino Hospital, University of Genoa, Genoa, Italy
    HIV Med 5:450-1. 2004
  6. ncbi Pharmacokinetics and pharmacodynamics of nelfinavir administered twice or thrice daily to human immunodeficiency virus type 1-infected children
    G Gatti
    Gaslini Childrens Hospital, Genoa, Italy
    Clin Infect Dis 36:1476-82. 2003
  7. ncbi Erythromycin resistance in Streptococcus pyogenes in Italy
    M Bassetti
    Infectious Diseases Department, University of Genoa, G Gaslini Children s Hospital, Genoa, Italy
    Emerg Infect Dis 6:180-3. 2000
  8. ncbi The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis
    M Cruciani
    Department of Infectious Diseases, HIV Screening Center, Verona, Italy
    Clin Infect Dis 33:1922-30. 2001

Collaborators

Detail Information

Publications8

  1. ncbi The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring
    G Gatti
    Department of Infectious Diseases, University of Genoa, Italy
    AIDS 13:2083-9. 1999
    ..To assess whether the neurological or gastrointestinal adverse effects of ritonavir correlate with parameters of ritonavir systemic exposure...
  2. ncbi Pharmacokinetics of rifabutin in HIV-infected patients with or without wasting syndrome
    G Gatti
    First Department of Infectious Diseases, University of Genoa, Genoa, Italy
    Br J Clin Pharmacol 48:704-11. 1999
    ..The purpose of the study was to compare the pharmacokinetic parameters of rifabutin obtained in a group of patients without wasting syndrome (NWS) with those obtained in a group with wasting syndrome (WS)...
  3. ncbi Indinavir pharmacokinetics and parmacodynamics in children with human immunodeficiency virus infection
    G Gatti
    Department of Infectious Diseases, University of Genoa, Genoa, Italy
    Antimicrob Agents Chemother 44:752-5. 2000
    ..Due to the low number of patients enrolled in this study, our results should be confirmed by a larger study...
  4. ncbi The relationship between ritonavir plasma trough concentration and virological and immunological response in HIV-infected children
    G Gatti
    I Department of Infectious Diseases c o G Gaslini Institute University of Genoa, Genoa, Italy
    HIV Med 3:125-8. 2002
    ..We studied a number of factors, including ritonavir plasma levels, and their capability of predicting response to therapy with ritonavir (RTV)...
  5. ncbi Tenofovir use in a patient with a severe renal impairment
    A Di Biagio
    Department of Infectious Diseases, San Martino Hospital, University of Genoa, Genoa, Italy
    HIV Med 5:450-1. 2004
  6. ncbi Pharmacokinetics and pharmacodynamics of nelfinavir administered twice or thrice daily to human immunodeficiency virus type 1-infected children
    G Gatti
    Gaslini Childrens Hospital, Genoa, Italy
    Clin Infect Dis 36:1476-82. 2003
    ..The variability of trough concentrations was extremely high, particularly among recipients of the twice-daily regimen, resulting in a higher number of patients with subinhibitory concentrations of nelfinavir in this group...
  7. ncbi Erythromycin resistance in Streptococcus pyogenes in Italy
    M Bassetti
    Infectious Diseases Department, University of Genoa, G Gaslini Children s Hospital, Genoa, Italy
    Emerg Infect Dis 6:180-3. 2000
    ..pyogenes treated with clarithromycin and in 22 (88%) of 25 patients with erythromycin-susceptible strains. The constitutive-resistant phenotype was correlated with failure of macrolide treatment...
  8. ncbi The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis
    M Cruciani
    Department of Infectious Diseases, HIV Screening Center, Verona, Italy
    Clin Infect Dis 33:1922-30. 2001
    ..78-1.56) were similar regardless of HIV-1 positivity of index cases. These data suggest that tuberculosis patients with HIV-1 infection are not intrinsically more infectious to their contacts than are HIV-1-negative tuberculosis patients...